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this would not reflect a substitution of
serine by asparagine but rather a
change to a threonine residue (ACT).
We think that the data presented by
Zhang and co-workers allow for either
of the following conclusions: Either
nucleotide position two at codon 63
in SSH1 is (highly) polymorphic and,
therefore, S63N reflects an innocuous
polymorphism rather than a true muta-
tion. Or the authors erroneously show a
different part of this patient’s genome,
but not the relevant heterozygous DNA
sections necessary to support their
previous notion that S63N is indeed
causative in DSAP and their current
assumption that these data indicate
somatic LOH in this patient suffering
from DSAP. Further we cannot see the
relevance of performing LOH studies in
DSAP by looking for the promotor
transition c.804G-A in ARPC3, con-
sidering that the authors themselves
state in a previous publication that this
nucleotide change was not only ob-
served in affected individuals from
family 2 but also in healthy control
individuals (Zhang et al., 2005a), thus
indicating that it is a common poly-
morphism rather than a mutation caus-
ing DSAP.
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TO THE EDITOR
To our knowledge, few groups focus on
the study of disseminated superficial
actinic porokeratosis (DSAP) etiopatho-
genesis, and they have not reported the
candidate genes of DSAP. Our results
confirmed the research of other groups,
and we also found variations of the SSH1,
ARPC3, and SART3 genes. Because we
have found no reports about the gene
causing DSAP, we published our findings
hoping to learn other researcher’s re-
sponses. Although Frank et al. (2007)
raised strong doubts about our results, we
are glad to discuss our study.
We never confirmed in our papers
that SSH1, ARPC3, or SART3 are the
genes causing DSAP; at this time, we
have reported three candidate genes for
DSAP. Like Frank et al. we are puzzled
why no other researchers have reported
on the disease gene, whether it is SSH1
or not.
In our papers, we suggest that SSH1,
ARPC3, or SART3 are candidate genes,
not the genes causing DSAP. In
12q23.2–24.1, there may be only one








Figure 1. Chromatograms of the normal and
mutated sequences and LOH in two affected
members in Family 2. (a) NM_018984.2:
c.188G4A (p.Ser63Asn) at SSH1.
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necessarily mean there is only one
candidate gene. We do not know
whether SSH1, ARPC3, and SART3 are
involved in the same pathway, but
some papers suggest that SSH1 and
ARPC3 may be involved in the actin
cytoskeleton pathway (Welch et al.,
1997; Pollard et al., 2000; Volkmann
et al., 2001; Niwa et al., 2002; Pelham
and Chang, 2002).
As to the heterozygous C/A-peak
perhaps it is caused by the low-resolu-
tion online image referred to (Figure 1
which is reproduced here). We are not
sure whether the S63N mutation is
innocuous or not, but it should be
confirmed by experiments.
We sincerely thank the authors for
their attention to our research. The
conclusions in our papers may be not
perfect, but the data generated by the
experiment are valid.
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TO THE EDITOR
An Associate Editor with expertise in
the field reviewed the online publica-
tion in question, along with an inde-
pendent observer, and agrees with Dr
Zhang. In addition, the Editor reviewed
all figures associated with this publica-
tion, including those submitted for
review purposes and those published
online and in print, and the Editor
agrees with Dr Zhang. The Editor
appreciates the concern over the valid-
ity of original data published in the JID,
and considers this case closed.
Lowell A. Goldsmith
Editor
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TO THE EDITOR
Pachyonychia congenita is a rare
autosomal-dominant disorder of keratin
that was first described in 1685 (Leach-
man et al., 2005). Named by Jadassohn
and Lewandowsky in 1906, this syn-
drome is characterized by hypertrophic
nail dystrophy, focal palmoplantar
keratoderma, follicular keratoses, and
other ectodermal features varying
by subtype. It is now well known that
pachyonychia congenita type 1 (PC-1),
also known as Jadassohn–Lewandowsky
syndrome, is caused by mutations in
either keratin 6a (K6a) or keratin 16
(K16), whereas pachyonychia con-
genita type 2 (PC-2), also known as
Jackson–Lawler syndrome, is caused
by mutations in keratin 6b (K6b) or
its expression partner keratin 17 (K17)
(Munro, 2001). Both subtypes have
hypertrophic nail dystrophy and painful
plantar keratoderma as the most
significant clinical findings with fea-
tures such as natal teeth, steatocysts,
and hair abnormalities being more
common in PC-2 and oral leukokera-
tosis more common in pachyonychia
congenita type 1 (Leachman et al.,
2005).
The number of patients worldwide
that are believed to have PC is between
1,000 and 10,000 (Kaspar, 2005). There
have been more than 82 mutations
published in the literature thus far with
all established mutations consistent
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